Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CMPI

Checkmate Pharmaceuticals (CMPI) Stock Price, News & Analysis

Checkmate Pharmaceuticals logo

About Checkmate Pharmaceuticals Stock (NASDAQ:CMPI)

Advanced Chart

Key Stats

Today's Range
$10.50
$10.50
50-Day Range
$10.37
$10.50
52-Week Range
$2.00
$10.50
Volume
N/A
Average Volume
142,261 shs
Market Capitalization
$231.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CMPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Checkmate Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CMPI Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

CMPI Stock Analysis - Frequently Asked Questions

Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) announced its earnings results on Friday, November, 12th. The company reported ($0.69) EPS for the quarter, beating analysts' consensus estimates of ($0.71) by $0.02.

Checkmate Pharmaceuticals (CMPI) raised $75 million in an initial public offering (IPO) on Friday, August 7th 2020. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Checkmate Pharmaceuticals investors own include Athenex (ATNX), KLX Energy Services (KLXE), TherapeuticsMD (TXMD), BioNTech (BNTX), Bolt Biotherapeutics (BOLT), Nabors Industries (NBR) and NGL Energy Partners (NGL).

Company Calendar

Last Earnings
11/12/2021
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:CMPI
CIK
1651431
Fax
N/A
Employees
28
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.40 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-83.92%
Return on Assets
-74.99%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.20
Quick Ratio
5.20

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.50 per share
Price / Book
4.20

Miscellaneous

Outstanding Shares
22,038,000
Free Float
8,242,000
Market Cap
$231.40 million
Optionable
Not Optionable
Beta
-4.81

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:CMPI) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners